Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection
暂无分享,去创建一个
E. Shimizu | A. Yamasaki | J. Kurai | Y. Kawasaki | Tomoya Harada | K. Yamaguchi | Yoichi Osawa | A. Tsukada | Hiroki Takami
[1] A. Analitis,et al. Temporal evolution of thoracocentesis-induced changes in spirometry and respiratory muscle pressures , 2017, Postgraduate Medical Journal.
[2] E. Tagaya,et al. Pulmonary Paragonimiasis: The Detection of a Worm Migration Track as a Diagnostic Clue for Uncertain Eosinophilic Pleural Effusion. , 2016, Internal medicine.
[3] K. Yoon,et al. Pleural fluid characteristics of pleuropulmonary paragonimiasis masquerading as pleural tuberculosis , 2014, The Korean journal of internal medicine.
[4] E. Nagayasu,et al. Paragonimiasis in Japan: a twelve-year retrospective case review (2001-2012). , 2015, Internal medicine.
[5] J. M. Salge,et al. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. , 2011, Chest.
[6] L. Sichletidis,et al. Expiratory Flow Limitation in Patients with Pleural Effusion , 2007, Respiration.
[7] K. Matsushima,et al. A Possible Role of TARC in Antigen-Specific Th2-Dominant Responses in Patients with Paragonimiasis westermani , 2004, International Archives of Allergy and Immunology.
[8] H. Mukae,et al. Elevated levels of thymus and activation‐regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani , 2002, Clinical and experimental immunology.
[9] S. Kohno,et al. Elevated IL‐5 levels in pleural fluid of patients with paragonimiasis westermani , 2001, Clinical and experimental immunology.
[10] G. Gibson,et al. Effects of pneumothorax or pleural effusion on pulmonary function. , 1985, Thorax.